



Why does chronic inflammation persist: An





Other (please specify with Rights Statement)
Document Version
Peer reviewed version
Citation for published version (Harvard):
Buckley, C 2011, 'Why does chronic inflammation persist: An unexpected role for fibroblasts', Immunology
Letters, vol. 138, no. 1, pp. 12-14. https://doi.org/10.1016/j.imlet.2011.02.010
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
NOTICE: this is the author’s version of a work that was accepted for publication in Immunology Letters. Changes resulting from the
publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be
reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was
subsequently published in Immunology Letters, VOL 138, ISSUE 1, July 2011, DOI: 10.1016/j.imlet.2011.02.010
Checked October 2015
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Why does chronic inflammation persist: An unexpected role for
fibroblasts
Christopher D. Buckley
Rheumatology Research Group, School of Immunity and Infection, MRC Centre for Immune
Regulation, College of Medical and Dental Sciences, University of Birmingham, Edgbaston B15
2TT, UK
Abstract
One of the most important but as yet unanswered questions in inflammation research is not why
inflammation occurs (we all get episodes of self limiting inflammation during the course of our
lives) but why it does not resolve. Current models of inflammation stress the role of antigen-
specific lymphocyte responses and attempt to address the causative agent. However, recent studies
have begun to challenge the primacy of the leukocyte and have instead focused on an extended
immune system in which stromal cells, such as fibroblasts play a role in the persistence of the
inflammatory lesion.
In this review I will illustrate how fibroblasts help regulate the switch from acute resolving to
chronic persistent inflammation and provide positional memory during inflammatory responses. In
chronic inflammation the normal physiological process of the removal of unwanted inflammatory
effector cells becomes disordered, leading to the accumulation of leucocytes within lymphoid
aggregates that resemble those seen in lymphoid tissue. I will describe how fibroblasts provide
survival and retention signals for leukocytes leading to their inappropriate and persistent
accumulation within inflamed tissue.
1. Background
Two characteristic features of chronic inflammatory reactions are their persistence and
predilection for certain sites. Why for example do some forms of inflammation resolve, yet
others do not? Why does arthritis localize predominantly to the joints compared to psoriasis
which localizes predominantly to the skin? It has been assumed that inflammation is a
stereotyped response that reflects a common or “public” set of shared pathways leading to
endothelial cell activation, leukocyte infiltration and tissue repair. However, there are
features of the inflammatory response that remain unique or “private” to the tissue where
inflammation occurs. The molecular and cellular basis for such tissue tropism has remained
elusive. There is now accumulating evidence that fibroblasts help define tissue topography,
provide positional memory and regulate the switch from resolving to persistent
inflammation.
The architecture of organs is very closely adapted to their function. Tissue resident cells
such as fibroblasts help define the microanatomy and architecture of organs and provide the
appropriate microenvironment in which specialized functions can occur. For example,
lymphoid tissues have defined architectural features, such as conduits, that differ from those
found in non lymphoid tissues. Until quite recently fibroblasts were thought to
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predominately provide physical structure to tissues. However, it has become increasingly
clear that in addition to their landscaping properties, fibroblasts are not just passive players
in immune responses, but play an active role in governing the persistence of inflammatory
disease, as well as enabling immunological memory to become established. The response of
the immune system to tissue damage involves a carefully choreographed series of cellular
interactions between immune and non-immune cells. As all inflammatory reactions take
place within a defined background of specialized stromal cells, understanding the biology of
fibroblasts in lymphoid and non lymphoid tissues is important in order to understand how
immune cell infiltrates become established and persistent in chronic immune mediated
inflammatory diseases.
During immune responses, peripheral blood leukocyte numbers are tightly regulated.
However, little is known about how leukocyte cell numbers within tissues are regulated
during inflammatory responses. Although there is considerable evidence that preferential
recruitment of cells to inflammatory lesions occurs during the initial stages of an
inflammatory response, the mechanisms regulating their survival and retention within
inflamed tissue remain largely unexplored. The interaction between leukocytes and stromal
cells during an acute inflammatory response ultimately leads to resolution of the
inflammatory focus. However, leukocyte interactions with stromal cells at sites of chronic
inflammation appear to lead to sustained leukocyte survival and retention with persistence of
the inflammatory lesion. Aberrant temporal and spatial expression of adhesion molecules,
chemokines/cytokines and their receptors has been shown to lead to persistent leukocyte
retention and survival in these inappropriately stable stromal cell microenvironments. While
normal homeostasis and resolution of acute inflammation depends on the right cell being in
the right place at the right time, it is likely that chronic inflammation involves immune cells
being positioned in the wrong place at the wrong time.
During the development of an immune response, immune cells have to be appropriately
positioned within lymph nodes and tissues, such that cognate interactions can occur. This
movement of cells to appropriate niches within immune organs is driven by chemokines and
their receptors. A longstanding observation has been that tissues undergoing chronic
inflammatory reactions contain infiltrates of distinct subsets of leukocytes that are often
organized into well defined lymphoid like structures (tertiary lymphoid tissue). For example,
within the rheumatoid synovium, B cells organized in clusters are in close contact with
macrophages, synoviocytes and CD8 T cells at the periphery of a lymphocyte-rich area
composed predominantly of CD4 T cells aggregated around post-capillary venules. Why this
characteristic pattern of leukocyte accumulation develops outside lymphoid tissues remains
obscure, but it turns out that cytokines such as lymphotoxin and constitutive chemokines
such as CXCL12/CXCL13 and CCL19/CCL21 play an important role in defining these
ectopic lymphoid structures.
In a series of papers over the last decade, our group has demonstrated that tissue-resident
fibroblasts are much more important than originally thought in determining both the switch
to persistence as well as the site at which inflammation occurs. In chronic inflammation, the
resolution phase is prolonged and disordered leading to the persistent accumulation of the
inflammatory infiltrate. We have found that this occurs because of the inappropriate
production of survival factors such as type I interferon [1] as well as the ectopic expression
and function of constitutive chemokines implicated in the retention of lymphocytes within
lymphoid tissues such as the bone marrow and lymph node [2-7]. We have shown that
fibroblasts isolated from different anatomical sites (synovium, skin, bone marrow, lymph
nodes) and from the same anatomical site (synovium) but different diseases (rheumatoid
versus osteoarthritis), display topographic differentiation and positional memory. Unlike the
case for endothelial cells, this fibroblast phenotype appears to be remarkably stable during in
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vitro cell culture [8,9]. However by changing the inflammatory stimuli, it is possible to
make the transcriptional profile of synovial fibroblasts resemble that of lymphoid
fibroblasts, implying that fibroblast regional identity can be modified by inflammation
[8-11]. We have explored the functional consequences of these anatomical differences using
models of leukocyte–stromal co-culture which have allowed us to determine the effects of
fibroblasts in regulating the behaviour (survival) and distribution (retention or emigration) of
different leukocyte subsets in tissues [12,13].
In order to better understand the biology of fibroblasts in inflammation and repair, we have
screened for fibroblast cell surface proteins that are differentially expressed in different
tissues using a monoclonal antibody strategy. This led to the identification of CD248
(Endosialin) as a novel, fibroblast and pericyte-specific transmembrane receptor [14] that is
specifically expressed in inflamed, but not normal adult tissue. On structural grounds CD248
is a member of an emerging family (which includes CD93 and CD141) that share the ability
to regulate innate immunity as well as tissue remodelling and repair. Whereas CD248
expression is high in many tissues throughout embryogenesis, it largely disappears in the
adult. However it is strongly re-expressed on interstitial fibroblasts and pericytes in inflamed
tissue and in a number of cancers [15].
Our work has allowed us to propose that a stromal area post code, predominantly defined by
fibroblasts, exists within tissues [11]. Our hypothesis predicts that components of this
stromal area post code become disordered during inflammation, leading to the accumulation
of lymphocytes in structures that resemble lymphoid tissues (Fig. 1). We have proposed that
inflammation is not generic, but contextual and therefore differences in the response of
different inflammatory diseases to therapy are likely to be due to intrinsic differences in the
behaviour of stromal cells within different microenvironments. Ignoring the contribution of
stromal cells to the pathogenesis of chronic inflammatory disease may account for the
failure of current therapies to affect a permanent cure. We suggest that stromal cells in
general and fibroblasts in particular offer a new family of organ specific targets to treat
chronic immune mediated inflammatory diseases such as rheumatoid arthritis, psoriasis and
inflammatory bowel disease.
2. Concluding remarks
Immune cells need to interact with a wide variety of cell types both within immune
(lymphoid) and peripheral tissues. During inflammation, stromal cells such as fibroblasts,
become activated and interact with infiltrating immune cells in a dynamic and site-specific
manner. Populations of leukocytes recruited to sites of inflammation should not be
considered in isolation, but in conjunction with the non-immune cells that help provide
survival, differentiation and positional cues upon which the formation and persistence of
leukocyte infiltrates depend. Our work suggests that targeting the stromal microenvironment
is likely to be an important strategy for future anti-inflammatory therapies.
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A. Tertiary lymphoid structures, found in diseased tissues such as the rheumatoid synovium
and thyroid gland share many features suggesting that similar subsets of fibroblasts may be
involved in inflammation and immunity. B. During inflammation in peripheral tissues,
fibroblasts become activated. Once inflammation resolves, these activated fibroblasts revert
back to a resting state. It is suggested that in some cases fibroblasts in tissues may take on
features of fibroblasts found in lymphoid tissues, and that these “ectopic” fibroblasts
contribute to the formation of tertiary lymphoid structures.
Buckley Page 5
Immunol Lett. Author manuscript; available in PMC 2012 January 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
